Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Contribution of Intra-arterial Thrombectomy in Acute Ischemic Stroke in Patients Treated With Intravenous Thrombolysis

Next Previous
Trial Profile

The Contribution of Intra-arterial Thrombectomy in Acute Ischemic Stroke in Patients Treated With Intravenous Thrombolysis

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alteplase (Primary) ; Alteplase (Primary)
  • Indications Ischaemic stroke; Thrombosis
  • Focus Therapeutic Use
  • Acronyms THRACE

Most Recent Events

  • 14 Jun 2022 Results from THRACE and other 2 studies evaluating Score for Symptomatic Intracranial Hemorrhage, published in the Stroke
  • 13 Sep 2019 Results of post-hoc analysis of the MT arm assessing the impact of WMH burden on functional outcome published in the Neurology
  • 30 Jan 2018 Results of subgroup analysis (n=304) assessing outcome after reperfusion therapies in patients with large baseline diffusion-weighted imaging stroke lesions, published in the Stroke Journal.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top